Rifabutin

Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.
Rifabutin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

NON-FDA APPROVED USES

  • Treatment of disseminated MAC in patients with AIDS (in combination with macrolide plus ethambutol).
  • Treatment of TB in patients with AIDS who are taking PIs or NNRTIs.
  • Treatment of latent TB in patients intolerant to INH. Rifabutin x 4 months can be considered.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

NON-FDA APPROVED USES

  • Treatment of disseminated MAC in patients with AIDS (in combination with macrolide plus ethambutol).
  • Treatment of TB in patients with AIDS who are taking PIs or NNRTIs.
  • Treatment of latent TB in patients intolerant to INH. Rifabutin x 4 months can be considered.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: February 9, 2020